Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
HTG Molecular Diagnostics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2024 | $15.00M | $15.00M - $15.00M | -$13.63M | -$1.06 | 1 |
| Dec 2023 | $6.40M | $6.40M - $6.40M | -$5.82M | -$4.63 | 1 |
| Dec 2022 | $6.36M | $6.36M - $6.36M | -$5.78M | -$20.32 | 1 |
| Dec 2021 | $8.94M | $8.94M - $8.94M | -$8.13M | -$29.52 | 1 |
| Dec 2020 | $8.23M | $8.23M - $8.23M | -$7.48M | -$56.76 | 1 |
| Dec 2019 | $19.26M | $19.26M - $19.26M | -$17.50M | -$99.45 | 1 |
| Dec 2018 | $21.96M | $21.96M - $21.96M | -$19.95M | -$126.72 | 1 |
| Dec 2017 | $13.80M | $13.80M - $13.80M | -$12.54M | -$364.392 | 1 |
| Dec 2016 | $5.50M | $5.50M - $5.50M | -$5.00M | -$659.70 | 1 |
| Dec 2015 | $4.02M | $4.02M - $4.02M | -$3.65M | -$844.20 | 1 |